Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

(Dana-Farber Cancer Institute) Researchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors - known as pNETs - that have dramatically different risks of recurrence following surgical treatment [or surgery]. The finding could yield predictive tests, ease anxiety in patients whose tumors are found to be unlikely to recur, while focusing vigilant follow-up monitoring on patients with pNETs having a higher rate of recurrence.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news